Primary Care POC Diagnostics Global Market Opportunities And Strategies To 2033
상품코드:1599017
리서치사:The Business Research Company
발행일:2024년 11월
페이지 정보:영문 321 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계 1차 진료 POC 진단 시장은 2018년 112억 4,242만 달러로 평가되었으며 CAGR 6.00% 이상에서 2023년까지 성장했습니다.
감염증의 높은 유병률
전염병의 유행은 역사적인 기간에 1차 케어 POC 진단 시장의 성장을 견인했습니다. 현장에서 빠르고 정확한 감지가 필요하기 때문에 POC 진단에 대한 수요를 견인했습니다. POC 진단은 의료 종사자가 즉시 검사를 실시할 수 있게 하고, 신속한 진단과 치료로 이어지고, 감염의 발생을 효과적으로 관리하는 데 매우 중요합니다. 예를 들면, 스위스에 본부를 두는 국제적인 비정부 조직인 World Economic Forum에 따르면 2023년에는 인플루엔자와 호흡기 합포체 바이러스(RSV) 등의 감염이 유행 이후 증가하고 있습니다. 미국에서는, 2023년 2월 시점에서 인플루엔자에 의한 추정 환자수는 2,400만명, 입원자 수는 26만 명, 사망자 수는 1만 6,000명이 되고 있습니다. 또한, 세계보건기구(WHO)에 의하면, 2022년에는 세계에서 1,060만명이 결핵에 감염해, 130만명이 결핵이 원인으로 사망하고 있습니다. 높은 증상이 1차 진료 POC 진단 시장의 성장을 이끌어 냈습니다.
목차
제1장 주요 요약
1차 진료 POC 진단 : 시장의 매력과 거시경제 상황
제2장 목차
제3장 표 일람
제4장 그림 일람
제5장 보고서 구성
제6장 시장 특징
일반적인 시장의 정의
개요
1차 진료 POC 진단 시장 정의와 세분화
제품별 : 시장 세분화
혈당 모니터링
심장 대사 검사 제품
감염증 검사 제품
응고 검사 제품
임신 및 생식 능력 검사 제품
종양 또는 암 마커 검사 제품
콜레스테롤 검사 제품
기타 제품
처방전별 : 시장 세분화
처방전 베이스
시판약(OTC) 검사
최종 용도별 : 시장 세분화
병원
진단센터
연구실
재택 케어의 설정
디지털 건강
기타 용도
제7장 주요 시장 동향
AI 통합에 의한 진단 정밀도와 효율 향상
진단을 효율화하기 위한 다조건 포인트 오브 케어 검사 장치의 개발
결과가 대폭 빨리 나오는 포인트 오브 케어 검사 시스템의 소개
경쟁 우위를 확보하기 위해 POC 테스트 제품의 승인과 허가에 중점
제8장 1차 진료 POC 진단 시장 : 거시경제 시나리오
COVID-19의 영향: 1차 진료 POC 진단 시장
우크라이나 전쟁의 영향: 1차 진료 POC 진단 시장
고인플레이션의 영향 : 1 차 진료 POC 진단 시장
제9장 세계 시장 규모와 성장
시장 규모
시장 성장 실적, 2018-2023
시장 성장 촉진요인, 2018-2023
시장 성장 억제요인, 2018-2023
시장 성장 예측, 2023-2028, 2033F
시장 성장 촉진요인, 2023-2028
시장 성장 억제요인, 2023-2028
제10장 세계의 1차 진료 POC 진단 시장 : 세분화
세계의 1차 진료 POC 진단 시장 : 제품별, 분석과 예측, 2018-2023, 2028F, 2033F
세계의 1차 진료 POC 진단 시장 : 처방전별, 분석과 예측, 2018-2023, 2028F, 2033F
세계의 1차 진료 POC 진단 시장 : 최종 용도별, 분석과 예측, 2018-2023, 2028F, 2033F
POCT의 세계 디지털 건강 시장 규모, 분석과 예측, 2018-2023, 2028F, 2033F
제11장 1차 진료 POC 진단 시장 : 지역·국가별 분석
세계의 1차 진료 POC 진단 시장 :지역별, 분석과 예측, 2018-2023, 2028F, 2033F
세계의 1차 진료 POC 진단 시장 : 국가별, 분석과 예측, 2018-2023, 2028F, 2033F
제12장 아시아태평양 시장
제13장 서유럽 시장
제14장 동유럽 시장
제15장 북미 시장
제16장 남미 시장
제17장 중동 시장
제18장 아프리카 시장
제19장 경쟁 구도와 기업 프로파일
기업 프로파일
F. Hoffman-La Roche Ltd
Siemens Healthineers AG
QuidelOrtho Corporation
Abbott Laboratories
Thermo Fisher Scientific Inc
제20장 기타 주요 기업 및 혁신 기업
Becton, Dickinson and Company
OraSure Technologies, Inc
Sekisui Chemical Co., Ltd.(Sekisui Diagnostics)
Danaher Corporation
bioMerieux SA
Cardinal Health, Inc
Werfen
Nova Biomedical
Randox Laboratories Ltd
EKF Diagnostics
PTS Diagnostics
Biosynex SA
Trinity Biotech plc
AccuBiotech Co. Ltd
Anbio Biotechnology(Anbio)
제21장 경쟁 벤치마킹
제22장 경쟁 대시보드
제23장 주요 인수합병(M&A)
Roche Holding AG Acquired LumiraDx
SD Biosensor Inc And SJL Partners Acquired Meridian Bioscience Inc.
Shineco Inc Acquired Changzhou Biowin Pharmaceutical Co
Primary care point-of-care (POC) diagnostics refer to medical diagnostic tools and tests that are used directly at the point of care, typically in a primary care settings, such as hospitals, nursing homes, clinicians' offices, homes and others. These tests provide immediate results, enabling healthcare providers to make swift decisions about a patient's treatment.
The primary care POC diagnostics market consists of sales, by entities (organizations, sole traders and partnerships), of primary care POC diagnostic tools and tests to deliver rapid, accurate and actionable data without the need to send samples to a centralized laboratory.
The global primary care POC diagnostics market was valued at $11,242.42 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 6.00%.
High Prevalence Of Infectious Diseases
The high prevalence of infectious diseases drove the growth of the primary care POC diagnostics market during the historic period. The rise in infectious diseases such as human immunodeficiency virus (HIV), tuberculosis, influenza, COVID-19 and others, drove demand for POC diagnostics due to their need for rapid, accurate detection in primary care settings. POC diagnostics enabled healthcare providers to perform immediate testing, leading to quicker diagnosis and treatment, which is crucial in managing infectious outbreaks effectively. For instance, in 2023, according to the World Economic Forum, a Switzerland-based international non-governmental organization, infections such as influenza and respiratory syncytial virus (RSV) have increased since the pandemic. In the USA, an estimated 24 million illnesses, 260,000 hospitalizations and 16,000 deaths from the influenza have occurred as of February 2023. Additionally, in 2022, according to the World Health Organization, 10.6 million people were infected with tuberculosis globally, with 1.3 million deaths attributed to tuberculosis. Therefore, the high prevalence of infectious diseases drove the growth of the primary care POC diagnostics market.
Development Of Multi-Condition POC Testing Devices To Streamline Diagnostics
Major companies operating in the primary care POC diagnostics market are developing POC testing device capable of diagnosing multiple health conditions. These multi-diagnostic tools enable healthcare providers to conduct various tests, such as for infectious diseases, chronic conditions and metabolic disorders, using a single device. This streamlines diagnostics, reduces time to results and improves patient care by allowing immediate, comprehensive assessments during a single visit. For example, in January 2023, Cipla Limited, an India-based pharmaceutical company, launched a POC testing device for multiple health conditions called Cippoint. Cippoint is engineered to test for various health conditions, thereby streamlining the diagnostic process. It is an immunofluorescence-based quantitative analyzer that allows healthcare professionals to get test results in 3 to 15 minutes. This makes it possible to make clinical decisions more quickly and efficiently. Cippoint allows healthcare providers to conduct tests at the site of patient care, reducing the need for laboratory visits and expediting diagnosis.
The global primary care POC diagnostics market is concentrated, with large players operating in the market. The top ten competitors in the market made up to 41.17% of the total market in 2023.
Primary Care POC Diagnostics Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global primary care POC diagnostics market as it emerges from the COVID-19 shut down.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for primary care POC diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The primary care POC diagnostics market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider primary care POC diagnostics market; and compares it with other markets.
The report covers the following chapters
Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by prescription and by end-use.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the primary care POC diagnostics market.
Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by prescription and by end-use in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for primary care POC diagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
1) By Product: Glucose Monitoring; Cardiometabolic Testing Products; Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy And Fertility Testing Products; Tumor Or Cancer Marker Testing Products; Cholesterol Testing Products; Other Products
2) By Prescription: Prescription-Based; Over-The-Counter (OTC) Testing
3) By End-Use: Hospitals; Diagnostic Centers; Research Laboratories; Home-Care Settings; Digital Health; Other End-Uses
Companies Mentioned: F. Hoffmann-La Roche AG; Siemens Healthineers AG; QuidelOrtho Corporation; Abbott Laboratories; Thermo Fisher Scientific Inc.
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; primary care POC diagnostics indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
1 Executive Summary
1.1 Primary Care POC Diagnostics - Market Attractiveness And Macro Economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 Primary Care POC Diagnostics Market Definition And Segmentations
6.4 Market Segmentation By Product
6.4.1 Glucose Monitoring
6.4.2 Cardiometabolic Testing Products
6.4.3 Infectious Disease Testing Products
6.4.4 Coagulation Testing Products
6.4.5 Pregnancy And Fertility Testing Products
6.4.6 Tumor Or Cancer Marker Testing Products
6.4.7 Cholesterol Testing Products
6.4.8 Other Products
6.5 Market Segmentation By Prescription
6.5.1 Prescription-Based
6.5.2 Over-The-Counter (OTC) Testing
6.6 Market Segmentation By End-Use
6.6.1 Hospitals
6.6.2 Diagnostic Centers
6.6.3 Research Laboratories
6.6.4 Home-Care Settings
6.6.5 Digital Health
6.6.6 Other End-Uses
7 Major Market Trends
7.1 Integration Of AI To Enhance Diagnostic Accuracy And Efficiency
7.2 Development Of Multi-Condition Point-Of-Care Testing Devices To Streamline Diagnostics
7.3 Introduction Of Point Of Care Testing Systems With Significant Faster Results
7.4 Focus On POC Testing Products Approvals And Clearances To Secure A Competitive Advantage
8 Primary Care POC Diagnostics Market - Macro-Economic Scenario
8.1 COVID-19 Impact On The Primary Care POC Diagnostics Market
8.2 Impact Of The War In Ukraine On The Primary Care POC Diagnostics Market
8.3 Impact Of High Inflation On The Primary Care POC Diagnostics Market
9 Global Market Size And Growth
9.1 Market Size
9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
10 Global Primary Care POC Diagnostics Market Segmentation
10.1 Global Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.2 Global Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.3 Global Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.4 Global Digital Health In POCT Market Size, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11 Primary Care POC Diagnostics Market, Regional and Country Analysis
11.1 Global Primary Care POC Diagnostics Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.2 Global Primary Care POC Diagnostics Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12 Asia-Pacific Market
12.1 Summary
12.2 Market Overview
12.2.1 Region Information
12.2.2 Market Information
12.2.3 Background Information
12.2.4 Government Initiatives
12.2.5 Regulations
12.2.6 Regulatory Bodies
12.2.7 Major Associations
12.2.8 Taxes Levied
12.2.9 Corporate Tax Structure
12.2.10 Investments
12.2.11 Major Companies
12.3 Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.4 Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.5 Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.6 Asia-Pacific Primary Care POC Diagnostics Market: Country Analysis
12.7 China Market
12.8 Summary
12.9 Market Overview
12.9.1 Country Information
12.9.2 Market Information
12.9.3 Background Information
12.9.4 Government Initiatives
12.9.5 Regulations
12.9.6 Regulatory Bodies
12.9.7 Major Associations
12.9.8 Taxes Levied
12.9.9 Corporate Tax Structure
12.9.10 Investments
12.9.11 Major Companies
12.10 China Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.11 China Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.12 China Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.13 India Market
12.14 India Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.15 India Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.16 India Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.17 Japan Market
12.18 Japan Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.19 Japan Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.20 Japan Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.21 Australia Market
12.22 Australia Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.23 Australia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.24 Australia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.25 Indonesia Market
12.26 Indonesia Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.27 Indonesia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.28 Indonesia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.29 South Korea Market
12.30 South Korea Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.31 South Korea Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.32 South Korea Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13 Western Europe Market
13.1 Summary
13.2 Market Overview
13.2.1 Region Information
13.2.2 Market Information
13.2.3 Background Information
13.2.4 Government Initiatives
13.2.5 Regulations
13.2.6 Regulatory Bodies
13.2.7 Major Associations
13.2.8 Taxes Levied
13.2.9 Corporate Tax Structure
13.2.10 Investments
13.2.11 Major Companies
13.3 Western Europe Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.5 Western Europe Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.6 Western Europe Primary Care POC Diagnostics Market: Country Analysis
13.7 UK Market
13.8 UK Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.9 UK Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.10 UK Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.11 Germany Market
13.12 Germany Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.13 Germany Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.14 Germany Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.15 France Market
13.16 France Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.17 France Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.18 France Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.19 Italy Market
13.20 Italy Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.21 Italy Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.22 Italy Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.23 Spain Market
13.24 Spain Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.25 Spain Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.26 Spain Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14 Eastern Europe Market
14.1 Summary
14.2 Market Overview
14.2.1 Region Information
14.2.2 Market Information
14.2.3 Background Information
14.2.4 Government Initiatives
14.2.5 Regulations
14.2.6 Regulatory Bodies
14.2.7 Major Associations
14.2.8 Taxes Levied
14.2.9 Corporate Tax Structure
14.2.10 Investments
14.2.11 Major companies
14.3 Eastern Europe Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.6 Eastern Europe Primary Care POC Diagnostics Market: Country Analysis
14.7 Russia Market
14.8 Russia Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.9 Russia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.10 Russia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15 North America Market
15.1 Summary
15.2 Market Overview
15.2.1 Region Information
15.2.2 Market Information
15.2.3 Background Information
15.2.4 Government Initiatives
15.2.5 Regulations
15.2.6 Regulatory Bodies
15.2.7 Major Associations
15.2.8 Taxes Levied
15.2.9 Corporate Tax Structure
15.2.10 Investments
15.2.11 Major Companies
15.3 North America Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.4 North America Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.5 North America Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.6 North America Primary Care POC Diagnostics Market: Country Analysis
15.7 USA Market
15.8 Summary
15.9 Market Overview
15.9.1 Country Information
15.9.2 Market Information
15.9.3 Background Information
15.9.4 Government Initiatives
15.9.5 Regulations
15.9.6 Regulatory Bodies
15.9.7 Major Associations
15.9.8 Taxes Levied
15.9.9 Corporate Tax Structure
15.9.10 Investments
15.9.11 Major Companies
15.10 USA Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.11 USA Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.12 USA Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.13 Canada Market
15.14 Canada Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.15 Canada Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.16 Canada Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16 South America Market
16.1 Summary
16.2 Market Overview
16.2.1 Region Information
16.2.2 Market Information
16.2.3 Background Information
16.2.4 Government Initiatives
16.2.5 Regulations
16.2.6 Regulatory Bodies
16.2.7 Major Associations
16.2.8 Taxes Levied
16.2.9 Corporate Tax Structure
16.2.10 Investments
16.2.11 Major Companies
16.3 South America Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.4 South America Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.5 South America Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.6 South America Primary Care POC Diagnostics Market: Country Analysis
16.7 Brazil Market
16.8 Brazil Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.9 Brazil Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.10 Brazil Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17 Middle East Market
17.1 Summary
17.2 Market Overview
17.2.1 Region Information
17.2.2 Market Information
17.2.3 Background Information
17.2.4 Government Initiatives
17.2.5 Regulations
17.2.6 Regulatory Bodies
17.2.7 Major Associations
17.2.8 Taxes Levied
17.2.9 Corporate Tax Structure
17.2.10 Investments
17.2.11 Major Companies
17.3 Middle East Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.5 Middle East Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18 Africa Market
18.1 Summary
18.2 Market Overview
18.2.1 Region Information
18.2.2 Market Information
18.2.3 Background Information
18.2.4 Government Initiatives
18.2.5 Regulations
18.2.6 Regulatory Bodies
18.2.7 Major Associations
18.2.8 Taxes Levied
18.2.9 Corporate Tax Structure
18.2.10 Major Companies
18.3 Africa Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.4 Africa Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.5 Africa Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
19 Competitive Landscape And Company Profiles
19.1 Company Profiles
19.2 F. Hoffman-La Roche Ltd
19.2.1 Company Overview
19.2.2 Products And Services
19.2.3 Business Strategy
19.2.4 Financial Overview
19.3 Siemens Healthineers AG
19.3.1 Company Overview
19.3.2 Products And Services
19.3.3 Business Strategy
19.3.4 Financial Overview
19.4 QuidelOrtho Corporation
19.4.1 Company Overview
19.4.2 Products And Services
19.4.3 Business Strategy
19.4.4 Financial Overview
19.5 Abbott Laboratories
19.5.1 Company Overview
19.5.2 Products And Services
19.5.3 Financial Overview
19.6 Thermo Fisher Scientific Inc
19.6.1 Company Overview
19.6.2 Products And Services
19.6.3 Business Strategy
19.6.4 Financial Overview
20 Other Major And Innovative Companies
20.1 Becton, Dickinson and Company
20.1.1 Company Overview
20.1.2 Products and Services
20.2 OraSure Technologies, Inc
20.2.1 Company Overview
20.2.2 Products and Services
20.3 Sekisui Chemical Co., Ltd. (Sekisui Diagnostics)
20.3.1 Company Overview
20.3.2 Products and Services
20.4 Danaher Corporation
20.4.1 Company Overview
20.4.2 Products and Services
20.5 bioMerieux SA
20.5.1 Company Overview
20.5.2 Products and Services
20.6 Cardinal Health, Inc
20.6.1 Company Overview
20.6.2 Products and Services
20.7 Werfen
20.7.1 Company Overview
20.7.2 Products and Services
20.8 Nova Biomedical
20.8.1 Company Overview
20.8.2 Products and Services
20.9 Randox Laboratories Ltd
20.9.1 Company Overview
20.9.2 Products and Services
20.10 EKF Diagnostics
20.10.1 Company Overview
20.10.2 Products and Services
20.11 PTS Diagnostics
20.11.1 Company Overview
20.11.2 Products and Services
20.12 Biosynex SA
20.12.1 Company Overview
20.12.2 Products and Services
20.13 Trinity Biotech plc
20.13.1 Company Overview
20.13.2 Products and Services
20.14 AccuBiotech Co. Ltd
20.14.1 Company Overview
20.14.2 Products and Services
20.15 Anbio Biotechnology (Anbio)
20.15.1 Company Overview
20.15.2 Products and Services
21 Competitive Benchmarking
22 Competitive Dashboard
23 Key Mergers And Acquisitions
23.1 Roche Holding AG Acquired LumiraDx
23.2 SD Biosensor Inc And SJL Partners Acquired Meridian Bioscience Inc.
23.3 Shineco Inc Acquired Changzhou Biowin Pharmaceutical Co
